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Abstract
Objective To investigate the effectiveness of facilitated physical activity
as an adjunctive treatment for adults with depression presenting in
primary care.
Design Pragmatic, multicentre, two arm parallel randomised controlled
trial.
Setting General practices in Bristol and Exeter.
Participants 361 adults aged 18-69 who had recently consulted their
general practitioner with symptoms of depression. All those randomised
had a diagnosis of an episode of depression as assessed by the clinical
interview schedule-revised and a Beck depression inventory score of
14 or more.
Interventions In addition to usual care, intervention participants were
offered up to three face to face sessions and 10 telephone calls with a
trained physical activity facilitator over eight months. The intervention
was based on theory and aimed to provide individually tailored support
and encouragement to engage in physical activity.
Main outcome measures The primary outcome was self reported
symptoms of depression, assessed with the Beck depression inventory
at four months post-randomisation. Secondary outcomes included use
of antidepressants and physical activity at the four, eight, and 12 month
follow-up points, and symptoms of depression at eight and 12 month
follow-up.
Results There was no evidence that participants offered the physical
activity intervention reported improvement in mood by the four month
follow-up point compared with those in the usual care group; adjusted
between group difference in mean Beck depression inventory score
−0.54 (95% confidence interval −3.06 to 1.99; P=0.68). Similarly, there
was no evidence that the intervention group reported a change in mood
by the eight and 12 month follow-up points. Nor was there evidence that
the intervention reduced antidepressant use compared with usual care
(adjusted odds ratio 0.63, 95% confidence interval 0.19 to 2.06; P=0.44)
over the duration of the trial. However, participants allocated to the
intervention group reported more physical activity during the follow-up
period than those allocated to the usual care group (adjusted odds ratio
2.27, 95% confidence interval 1.32 to 3.89; P=0.003).
Conclusions The addition of a facilitated physical activity intervention
to usual care did not improve depression outcome or reduce use of
antidepressants compared with usual care alone.
Trial registration Current Controlled Trials ISRCTN16900744.
Introduction
Depression is one of the most common reasons for consulting
a general practitioner within the United Kingdom, and its
associated economic burden is considerable.1 Although
antidepressants are effective, many patients and healthcare
professionals would like other options to be available as an
alternative or adjunct to drug therapy.2 Some evidence3 shows
that physical activity might be an effective treatment and it has
been recommended as part of the latest guidelines on depression
from the National Institute for Health and Clinical Excellence.4
A Cochrane review3 of physical activity interventions and
depression suggested a pooled standardised mean difference of
0.82 (95% confidence interval 0.51 to 1.12), based on 23 trials
and 907 participants. This evidence on the effectiveness of
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physical activity should be considered with caution, however,
owing to several methodological issues. Many of the included
trials were small, with even the largest reporting fewer than 50
participants per treatment arm. The majority of trials recruited
participants from non-clinical settings, often offering financial
or other incentives to those who agreed to participate. Most
studies involved relatively short follow-up periods so that
evidence for a more sustained benefit is limited, and, finally,
few of the interventions designed to increase physical activity
were readily applicable to clinical practice. It is therefore
difficult to be confident about generalising the pooled results
of the meta-analysis3 to the population with depression treated
by doctors in primary care.
We report the findings of the TREAD (TREAtment of
Depression with physical activity) study,5 which investigated
the effectiveness of a facilitated physical activity intervention
in addition to usual care for the treatment of depression in adults
presenting in primary care.
Methods
The TREAD study was a pragmatic, multicentre, two arm
parallel randomised controlled trial. Adults presenting with a
new episode of depression were randomised to receive either
usual care from their general practitioner or usual care plus the
TREAD intervention. Full details of the protocol have been
published previously5 and the results are available in the final
report of the trial.6
Recruitment of participants and baseline
assessment
Our inclusion criteria were broad as we wanted to recruit adults
presenting in primary care with new episodes of depression.
However, we excluded those who had failed to respond
previously to antidepressants as this group often requires more
intensive interventions.We also excluded those aged 70 or more
as we thought this older group might have greater physical
health problems, making the intervention more difficult to
implement. Most of the participants were identified by their
general practitioner during routine consultations, although in
some practices the electronic patient records were also regularly
screened for details of adults with a recent diagnosis of
depression to identify any potentially eligible people. The study
targeted adults aged 18-69 who either were not taking
antidepressants at the time of assessment or had been prescribed
antidepressants within four weeks of assessment but had not
taken these for at least four weeks before that period. General
practitioners excluded those who were unable to complete self
administered questionnaires in English; had medical
contraindications to physical activity; were being treated for
psychosis, bipolar disorder, or major substance misuse; or were
pregnant or breast feeding at the time of assessment. At baseline,
patients were only eligible to be included in the study if they
had a current diagnosis of ICD-10 (international classification
of diseases, 10th revision) depressive episode F32 from the
computerised clinical interview schedule-revised,7 8 a Beck
depression inventory9 score of at least 14, and provided written
informed consent. Recruitment for the trial took place between
August 2007 and October 2009 in general practices in the south
west of England.
Randomisation, concealment, and blinding
Randomisation was stratified to take account of self reported
antidepressant use (yes, no) and was minimised by severity of
depression (clinical interview schedule-revised score ≤25, 26-33,
≥34 at baseline), recruiting centre (Bristol, Exeter), and self
reported level of physical activity (≤1, 2-3, ≥4 days per week,
with at least 30 minutes of moderate or vigorous intensity
physical activity). Treatment allocation, concealed from the
study researchers using an automated telephone system, was
administered remotely and employed a computer generated
code. Owing to the nature of the intervention, none of the
participants, general practices, clinicians, or researchers
performing the outcome assessments could be blinded to
treatment allocation.
Follow-up
Collection of follow-up data took place between August 2008
and October 2010. Participants were asked to provide data at
three time points; four, eight, and 12months post-randomisation,
using a self completion questionnaire to eliminate any observer
bias. The four month follow-up was chosen as the primary
outcome endpoint as it represented the stage in the intervention
period at which we expected to observe the largest effect, as
well as being an appropriate point at which to review the
participants’ progress from a clinical perspective. The eight
month follow-up broadly coincided with the end of the
intervention delivery period,. Data were collected at 12 months
to investigate any longer term effects of the intervention on
study outcomes. To maximise retention, researchers arranged
to meet participants to supervise their data collection at the four
and 12 month follow-up points, whenever possible. Participants
who were unable to attend these follow-up sessions were
contacted by telephone to arrange a further appointment or were
sent the questionnaire by post if a face to face session was not
possible. Due to restricted resources, eight month follow-up
was done solely by postal questionnaire.
Intervention and comparator (usual care)
Participants in both groups were asked to continue to follow
the healthcare advice of their general practitioner for their
depression and were therefore free during the trial to access any
treatment usually available in primary care, including the use
of antidepressants, counselling, referral to “exercise on
prescription” schemes, or secondary care mental health services.
In addition to this usual care, participants allocated to the
intervention group were also offered assistance from a physical
activity facilitator.
The intervention was based on theory10 11 and was designed to
provide individually tailored support and encouragement to
engage in physical activity (see box for a summary of the key
features). A manual6 was devised to guide the physical activity
facilitators, which described a range ofmotivational interviewing
techniques and behavioural strategies to promote participants’
uptake of locally available opportunities for physical activity.
The aim was to encourage sustainable activity that could be
easily incorporated into the participants’ lifestyle. The aspiration
was for the participants to engage in moderate or vigorous
activity for 150 minutes a week in bouts of at least 10 minutes,
but if that seemed unrealistic then the facilitator encouraged
any increase in physical activity, whatever the intensity.
The intervention programme comprised an initial hour long face
to face assessment session followed by two short telephone
contacts, then a further face to face meeting for half an hour.
Over the course of 6-8-months, the physical activity facilitator
offered up to eight further telephone contacts and one more face
to face half hour meeting. The scheduling of sessions was left
to the discretion of the physical activity facilitator and the
participant, although the intention was to have most sessions
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Key features of TREAD (TREAtment of Depression with physical activity) intervention
Designed to improve long term adherence to physical activity
Employed motivational interviewing techniques
Individually tailored to reflect participants’ needs and preferences
Encouraged autonomy and choice of physical activity
Provided advice, support, and encouragement
Promoted physical activity of all intensities
Described in a manual to aid standardisation and dissemination
Delivered by a physical activity facilitator
Consisted of up to three face to face sessions and 10 telephone calls
Lasted about 6-8 months, with most facilitator time in first four months
early in the intervention period, to encourage an increase in
physical activity, whereas the later sessions were less frequent
and designed to maintain any change. The expectation was that
at least five sessions, including one face to face meeting, would
have been completed well before the primary outcome endpoint
at four months post-randomisation. The physical activity
facilitators worked part-time, came from a psychology or an
exercise science background, and received training in delivering
the TREAD intervention and working with participants who
had depression. The facilitators were regularly supervised by
some of the investigators.
Outcomes
The primary outcome was the Beck depression inventory
(version II) at the four month follow-up. The Beck depression
inventory is a self report 21 item scale, with higher scores
indicating more severe depression.9 The score was treated as
both a continuous outcome (range 0-63) and a binary outcome
(<10 indicating recovery).
Secondary outcomes included the Beck depression inventory
at eight and 12 months post-randomisation and a self reported
binary measure of antidepressant use from the four, eight, and
12month follow-up. Physical activity was measured at all three
time points using a self completion seven day recall diary in
which participants were asked to record 10 minute bouts of
light, moderate, and vigorous physical activity in the week
before the assessment. We transformed these data into a single
weighted score of MET minutes of physical activity per week
(where MET was the metabolic equivalent of the task as a ratio
to the basal rate). METminutes were calculated by multiplying
the number of minutes of light activity by 2, moderate activity
by 4.5, and vigorous activity by 7.5.12 Current government
guidelines suggest that adults should carry out 150 minutes of
moderate or vigorous physical activity per week.13We therefore
created a binary variable (<1000METminutes per week, ≥1000
METminutes per week) as an approximate guide as to whether
participants were meeting this guideline. The recall diary for
physical activity was compared with accelerometry data after
the four month follow-up in a subset of participants (n=99). Full
details of this comparison are in the report of the trial6 and
indicate that there was reasonable agreement between the two
measures, considering that accelerometry and the recall diary
measured somewhat different aspects of physical activity. There
was, however, greater variability between the accelerometer
and recall diary for more vigorous activity. Two further
secondary outcomes (health related quality of life14 and outcome
expectations of physical activity15) were also assessed and
analysed; the results are also available in the full trial report.6
Statistical analysis
The statistical analysis and reporting of this trial followed the
Consolidated Standards of Reporting Trial guidelines,16 and the
study protocol was published before the completion of data
collection.5 All analyses were performed in Stata 11.1,17
following a prespecified analysis plan approved by the trial
steering committee. The primary comparative analyses were
conducted using an intention to treat approach without
imputation of missing data on outcomes. The primary outcome
data (total Beck depression inventory score at four months
post-randomisation) were analysed in both continuous and
binary form. The continuous outcome was analysed in a linear
regression model and is presented as the adjusted difference in
mean score between the intervention and usual care groups,
taking into account the baseline Beck depression inventory
score. The binary outcome was analysed in a logistic regression
model and is presented as the adjusted odds ratio of recovery
in the intervention group compared with the control group,
taking into account the baseline Beck depression inventory
score. To account for the variables used for stratification and
minimisation in the randomisation process, all models were
adjusted for baseline antidepressant use, clinical interview
schedule-revised score, recruiting centre, and level of physical
activity.
As part of the secondary analyses, the Beck depression inventory
score was also considered in a linear repeated measures analysis
using data from the four, eight, and 12 month follow-up points.
Antidepressant use and physical activity were considered as
binary outcomes in a logistic regression model using data from
the four month follow-up and also in a logistic repeated
measures analysis using data from all three time points. All the
analyses using repeated measures examined the possibility of
a difference in the effect size over time by introducing a time
by group interaction term. The intervention group was coded
“1” and usual care coded “0” in all analyses—therefore a
negative difference in means indicates lower Beck depression
inventory scores (and better health) in the intervention group,
and an odds ratio of more than 1 represents a greater proportion
(of individuals recovered, of antidepressants used, or of being
physically active) in the intervention group.
Several additional sensitivity analyses of the primary outcome
were planned. We investigated the influence of missing data on
the results by imputing missing data using multiple imputation
chained equation methods (Stata ice procedure version 1.9.5
dated 15 April 2011).17 18 The imputation model included all
those variables associated with “missingness” in the primary
outcome at four months post-randomisation as well as additional
measures for symptoms of depression (Beck depression
inventory score) at later follow-ups. We also used robust
estimates in Stata to account for clustering by general practice
and a previously published method to account for clustering by
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2012;344:e2758 doi: 10.1136/bmj.e2758 (Published 6 June 2012) Page 3 of 13
RESEARCH
physical activity facilitator.19As per protocol analyses are likely
to be biased, we estimated the complier-average causal effect20
using instrumental variable regression techniques, to obtain an
unbiased estimate of the effectiveness of the intervention in
those who received an “adequate dose” before measurement of
the primary outcome at four months post-randomisation. This
methodology compares the outcome for those who received an
“adequate dose” of the intervention (compliers) with a
comparable group of “would be” compliers in the usual care
group. For the purposes of this analysis on complier-average
causal effect, an “adequate dose” was defined in the analysis
plan as having received at least five sessions of the intervention
by four months post-randomisation, since this reflected the way
in which the intervention was structured. In the instrumental
variable approach adopted, randomisation is the instrument,
with the assumption that the effect of randomisation on the
outcome only operates through its effect on treatment. Finally,
two preplanned subgroup analyses for the primary outcome
were conducted by including an interaction between treatment
allocation and severity of depression or level of physical activity
at baseline.
Our sample size calculation indicated that 360 randomised
participants would provide 82% power to detect a third of a
standard deviation difference in the Beck depression inventory
score as a continuous outcome and 80% power to detect a 15%
difference in recovery when considering the Beck depression
inventory score as a binary outcome, allowing for a 5% two
sided α and a maximum attrition rate of 15%. This sample size
calculation was the result of a revision made in the early stages
of the trial, following the observation that certain assumptions
from the original study protocol did not hold true. Firstly, we
had originally expected that 10% of the sample would have been
taking antidepressants at baseline and had intended to exclude
them from the main comparative analysis. However, because
around 50% of those randomised into the study were taking
antidepressants at baseline, we decided to include everyone in
the analysis. This decision was also informed by the results of
a trial of internet psychotherapy that did not report any change
in antidepressant use in the usual care arm.21 Randomisation
was, in any case, stratified according to antidepressant use from
the outset. We had also assumed that around 65% of participants
receiving usual care would have recovered by the four month
follow-up, but results from a trial conducted in a similar
population showed that only 20% recovered.22 Finally, our
recruitment rate was lower than we expected. The trial steering
committee and data monitoring committee therefore approved
a recalculation of the sample size required so as to reflect the
above changes, resulting in the final sample size of 360 cited
previously. Further details are provided elsewhere.6 5
Results
Sixty five practices agreed to take part in the study, referring a
total of 766 patients to the research team. Of 490 people
assessed, 361 eligible and consenting participants were
successfully randomised (figure⇓). At baseline, 182 people were
allocated to the intervention arm and 179 to the usual care arm.
Eighty per cent of the participants provided data at the primary
outcome follow-up point. Participants who provided follow-up
information on the primary outcomeweremore likely at baseline
to be older, own their own home, be educated to “A” level or
beyond, be in receipt of counselling, smoke cigarettes, and drink
alcohol less than weekly than those who did not provide such
information. Fewer participants were lost to follow-up at the
four and 12month time points, where face to face data collection
had taken place.
The randomised groups were similar on entry to the trial,
although the proportion of people employed or in education,
married or cohabiting, receiving counselling, or not smoking
was slightly higher in the intervention group than in the usual
care group (table 1⇓).
Intervention implementation
The physical activity intervention was delivered according to
the manual by all five physical activity facilitators, with
allocation of participants to each facilitator based on workload,
availability, and location. The number of patients seen by each
facilitator ranged from 25 to 58. Adherence to the intervention
was generally good. A mean 7.2 (standard deviation 4.1)
sessions was completed, with 56% (n=102) of participants
receiving an adequate dose of at least five contacts by four
months post-randomisation. Only 6% (n=11) of the intervention
group failed to attend the first appointment with their physical
activity facilitator and 71% (n=129) had received an adequate
dose of intervention by the end of their involvement in the trial.
Primary outcome: short term symptoms of
depression
When the Beck depression inventory score was treated as a
continuous variable, there was no evidence that participants in
the intervention group had a better outcome at four months than
those in the usual care group (table 2⇓). The intervention group
reported slightly lower scores at the four month follow-up, with
an adjusted between group difference in mean score of −0.54
(95% confidence interval −3.06 to 1.99; P=0.68). The proportion
of participants who reported a score of less than 10 (that is,
“recovered”) was slightly smaller in the intervention group at
four months post-randomisation (28.2% in the intervention arm
compared with 35.6% in the usual care arm), although there
was no evidence of a difference between the randomised groups
(adjusted odds ratio 0.66, 95% confidence interval 0.4 to 1.11;
P=0.12).
Sensitivity analyses for primary outcome
Table 2 summarises the results of the additional sensitivity
analyses. Firstly, the analysis was performed after multiple
imputation of missing data using multiple imputation chained
equation methods. The results indicated that missing data might
have led to a slight underestimation of the treatment effect, but
this was insufficient to alter the overall interpretation of the trial
findings. The impact of clustering by practice or by physical
activity facilitator was also investigated, but did not alter the
results. The calculation of complier-average causal effect
estimates indicated that the difference in Beck depression
inventory scores between the two treatment groups for those
participants who received an “adequate dose” of the intervention
was larger than the original intention to treat estimate, although
the surrounding confidence interval was wide. Two a priori
subgroup analyses provided no evidence to suggest that baseline
severity of depression (P=0.87) or level of physical activity
(P=0.77) had any influence on the difference between
intervention and usual care groups.
Secondary outcomes
Longer term symptoms of depression
Table 3⇓ presents the results of the repeated measures analysis,
in which data from up to three follow-up points were included
per participant. There was no evidence of a difference between
the treatment groups over the duration of the study (adjusted
difference in mean Beck depression inventory score −1.20, 95%
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confidence interval −3.42 to 1.02; P=0.29) or of any differential
effect across the three follow-up points (time by treatment
interaction P=0.61).
Antidepressant use
The proportion of participants reporting use of antidepressants
was smaller in both groups at the end of the trial compared with
baseline (table 4⇓). However, there was no evidence to suggest
any difference between the groups at either the four month
follow-up point (adjusted odds ratio 1.20, 95% confidence
interval 0.69 to 2.08; P=0.52) or over the duration of the trial.
Nor was there any evidence of any differences in treatment
effect across the three follow-up points (time by treatment
interaction P=0.22).
Physical activity
Table 5⇓ shows there was some evidence for a difference in
reported physical activity between the groups at four months
post-randomisation (adjusted odds ratio 1.58, 0.94 to 2.66;
P=0.08) and much stronger evidence for this effect when data
from all three follow-up points were considered together.
However, there was no evidence that the difference between
the groups changed over the duration of the study (time by
treatment interaction P=0.71).
Discussion
Adults presenting with depressing in primary care and receiving
the TREAD (TREAtment of Depression with physical activity)
intervention in addition to usual care reported increased physical
activity compared with those receiving usual care alone,
although there was no evidence to suggest that the intervention
brought about any improvement in symptoms of depression or
reduction in antidepressant use at the four month follow-up
point.
We considered whether our result was sufficiently precise to
rule out the possibility of a beneficial effect. The most
statistically powerful analysis was using the Beck depression
inventory as a continuous outcomemeasure. The results for our
primary analysis indicated an adjusted between group difference
in mean Beck depression inventory scores of −0.54 (95%
confidence interval −3.06 to 1.99). It is difficult to define
precisely what would constitute a clinically important treatment
effect, but the National Institute for Health and Clinical
Excellence guideline panel23 have suggested that this could
correspond to around 3 points or 0.35 standard deviations at
baseline on the Hamilton depression rating scale24 and close to
the 0.33 standard deviations used in our power calculation. The
equivalent difference in terms of Beck depression inventory
score would be between 4.1 and 3.9 points, respectively, based
on our observed standard deviation of 11.8 points at four months
post-randomisation. This suggests that we have excluded the
possibility, at least with 95% confidence, that the intervention
added to usual care is clinically effective in improving symptoms
of depression compared with usual care alone.
Strengths and weaknesses of the study
Our trial recruitment rate was lower than initially planned but
we reviewed and amended the variables in our power calculation
and subsequently achieved the revised recruitment target. While
our retention rate at the four month follow-up was, at 80%,
slightly lower than that outlined in the protocol, our sensitivity
analyses indicated that missing data probably had little impact
on our findings. Moreover, our findings show that the resulting
dataset was sufficiently large to estimate confidence intervals
that excluded a clinically meaningful difference in outcome
between the groups. The trial is one of the largest trials of
physical activity and depression to have taken place in primary
care. Baseline comparability of the two treatment groups was
good. Although we used self reported outcome data in an effort
to eliminate any observer bias, it is possible that the participants’
responses could have been influenced, to some degree, by their
knowledge of their treatment allocation. Physical activity is
notoriously difficult to measure and the self reported assessment
could have been biased by knowledge of the treatment
allocation. The effect of the intervention on physical activity
outcomesmust therefore be treated with some caution. However,
comparison of the data reported in the physical activity recall
diary with accelerometry data indicated reasonable agreement
between the twomeasures.6 If knowledge of treatment allocation
was to bias the responses to physical activity, then it might also
be expected to have led to a difference in the scores for
symptoms of depression.
Strengths andweaknesses in relation to other
studies and important differences in results
A recent systematic review25 of physical activity and depression
only included studies of patients with a diagnosis of depression
and a follow-up period of more than 16 weeks. Within this
restricted analysis there was no longer any evidence for a
beneficial effect of physical activity interventions on symptoms
of depression. Our results are therefore consistent with that
finding, although studies of non-clinical populations over shorter
periods suggest a possible benefit.3
One important difference between TREAD and previous studies
was the development of an intervention that aimed specifically
to produce more lasting change in physical activity levels.10
Adherence to the intervention supports the perceived
acceptability of using the TREAD approach,6 and the reported
increase in physical activity sustained over the entire 12 month
follow-up period indicates that our purpose in designing the
intervention was achieved. Indeed the results show a slight
increase in the apparent effectiveness of the intervention over
the course of the study, which is unusual in trials designed to
boost physical activity, with either depressed or non-depressed
participants.26 27 The effect on physical activity reported here
(adjusted odds ratio 2.27, 95% confidence interval 1.32 to 3.89)
was also larger than the pooled estimate from a recent review
of exercise referral schemes (pooled risk ratio 1.16, 95%
confidence interval 1.03 to 1.30).27 The fact that participants
were recruited directly from primary care and were not selected
on the basis of their interest or motivation to engage in physical
activity adds further weight to the success of the intervention.
It is, however, possible that only those participants with
relatively positive views of physical activity would have agreed
to be involved in the first place.
Meaning of the study, possible explanations,
and implications for clinicians and policy
makers
The main implication of our results is that advice and
encouragement to increase physical activity is not an effective
strategy for reducing symptoms of depression. Although our
intervention increased physical activity, the increase may not
have been sufficiently large to influence depression outcomes.
The absolute difference between the randomised groups in terms
of the proportion meeting our physical activity threshold was
about 15% so there is still a possibility that physical activity
itself might have some benefits for depression. However, this
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does not alter our conclusion about the lack of effectiveness of
facilitated physical activity as an adjunct treatment to usual care
for depression. The TREAD intervention was a pragmatic and
acceptable intervention that could be implemented in the
National Health Service and increase physical activity levels
but had no impact on symptoms of depression.
Unanswered questions and future research
There is empirical evidence from experimental studies in
volunteers that some people report improved affect and pleasure
while exercising at moderate levels. In contrast, vigorous activity
is almost always experienced as unpleasant while it is performed
but there is improved affect and pleasure shortly after finishing,
perhaps resulting from endogenous opioid activity, the “runner’s
high.”28 This might explain why some participants in the trial
reported that physical activity helped to improve their mood.29
Perhaps an intervention that focused only on vigorous physical
activity might be more effective, although we suspect that this
would be less acceptable to participants and difficult or even
impossible to sustain. A better understanding of the underlying
mechanisms that might link physical activity and mood could
lead to new therapeutic opportunities.
The TREAD intervention increased self reported physical
activity, an effect that lasted beyond the duration of the
intervention. Our approach towards increasing physical activity
put emphasis on promoting choice and autonomy. It did not rely
simply on giving advice but drew on a range of behaviour
change techniques. Physical activity might have benefits for
patients with medical conditions such as obesity, diabetes, and
cardiovascular disease. This approach to increase physical
activity might be useful for people with or without depression
who also have these other medical conditions.
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What is already known on this topic
Depression is a leading contributor to disability in the United Kingdom and is associated with a decrement of health greater than many
other chronic diseases
Many patients and healthcare professionals would like an effective and accessible non-drug treatment for depression
Numerous studies have reported the positive effects of physical activity but most of the current evidence originates from small non-clinical
samples using interventions that are not practicable in healthcare settings
What this study adds
A physical activity intervention in addition to usual care did not improve symptoms of depression or reduce the use of antidepressants
compared with usual care alone
The intervention increased self reported physical activity and this effect was sustained for 12 months
Clinicians and policy makers should alert people with depression that advice to increase physical activity will not increase their chances
of recovery from depression
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Tables
Table 1| Baseline characteristics of adults with depression randomised to usual care plus facilitated physical activity or to usual care only.
Values are numbers (percentages) unless stated otherwise
Usual care group (n=179)Intervention group (n=182)Characteristics
96 (54)96 (53)Recruited via Bristol centre
82 (46)92 (51)Physically active at least one day a week
162 (91)159 (87)Mild or moderate depression*
101 (56)106 (58)Currently taking antidepressants
91 (51)90 (46)Current depressive episode >6 months
122 (68)132 (73)History of depression
107 (60)117 (64)Previously prescribed antidepressants
114 (64)115 (63)Immediate family member ever been depressed
63 (35)59 (32)Male
166 (93)170 (95)White
76 (43)91 (50)Married or cohabiting
27 (15)38 (21)Currently attending counselling
132 (74)122 (67)Employed, studying, or training
84 (47)87 (48)Home owner
98 (55)93 (51)Educated to A level or beyond
65 (37)55 (31)Current smoker
72 (41)69 (39)Drinking alcohol at least weekly
48 (28)45 (25)At least 1000 MET minutes of physical activity a week
38.8 (12.7)40.9 (12.5)Mean (SD) age at referral
50.3 (9.9)51.4 (9.8)Mean (SD) SF-12 standardised physical health score
26.8 (7.8)26.5 (6.9)Mean (SD) SF-12 standardised mental health score
32.1 (9.5)32.1 (9.0)Mean (SD) Beck depression inventory score
28.2 (7.8)28.0 (7.9)Mean (SD) clinical interview schedule-revised score
MET=metabolic equivalent of the task.
*According to clinical interview schedule-revised.
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Table 2| Mean Beck depression inventory (BDI) score and differences in means at four month follow-up of adults with depression allocated
to usual care plus facilitated physical activity or to usual care only
Difference in means* (95% CI), P value
Mean (SD) BDI
scoreNoStudy arm CACE estimate
ITT estimate adjusted
for clustering by PAF
ITT estimate adjusted
for practice clusteringMICE estimateITT estimate
−0.86 (−4.85 to
3.13), 0.67
−0.53 (−3.00 to 1.95),
0.68
−0.54 (−3.06 to 1.99),
0.67
−0.76 (−3.37 to
1.84), 0.56
−0.54 (−3.06 to
1.99), 0.68
16.12 (11.34)142Intervention
16.87 (12.63)146Usual care
ITT=intention to treat; MICE=multiple imputation chained equation; PAF=physical activity facilitator; CACE=complier-average causal effect.
*Adjusted for baseline Beck depression inventory score, antidepressant use, severity of depression, level of physical activity, and recruiting centre.
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Table 3| Means and differences in mean Beck depression inventory scores at four, eight, and 12 month follow-up in adults with depression
allocated to usual care plus facilitated physical activity or to usual care only
Repeated measures difference in means* (95% CI), P value
No (mean score) at follow-up
Study arm 12 months8 months4 months
−1.20 (−3.42 to 1.02), 0.29133 (12.59)115 (14.29)142 (16.12)Intervention
122 (13.47)107 (16.08)146 (16.87)Usual care
308255222288Total No
*Adjusted for baseline antidepressant use, severity of depression, level of physical activity, and recruiting centre.
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Table 4| Percentages and odds ratio of using antidepressants at four, eight, and 12 month follow-up in adults with depression allocated
to usual care plus facilitated physical activity or to usual care only
Repeated measures odds ratio* (95% CI), P valueNo (%) at follow-upStudy arm
12 months8 months4 months
0.63 (0.19 to 2.06), 0.44133 (35)115 (42)142 (59)Intervention
123 (42)105 (46)147 (53)Usual care
307256220289Total No
*Adjusted for baseline antidepressant use, severity of depression, level of physical activity, and recruiting centre.
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Table 5| Percentages and odds ratio of reporting physical activity (≥1000 metabolic equivalent of task minutes a week) at four, eight, and
12 month follow-up in adults with depression allocated to usual care plus facilitated physical activity or to usual care only
Repeated measures odds ratio* (95% CI), P value
No (%) at follow-up
Study arm 12 months8 months4 months
2.27 (1.32 to 3.89), 0.003123 (58)95 (63)136 (52)Intervention
114 (40)81 (49)136 (43)Usual care
293237176272Total No
*Adjusted for baseline antidepressant use, severity of depression, level of physical activity, and recruiting centre.
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Figure
Flow of participants through trial
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